NUVATION BIO INC (NUVB) Forecast, Price Target & Analyst Ratings

NYSE:NUVB • US67080N1019

Current stock price

5.12 USD
+0.04 (+0.79%)
At close:
5.2 USD
+0.08 (+1.56%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUVATION BIO INC (NUVB).

Forecast Snapshot

Consensus Price Target

Price Target
$11.83
+ 131.09% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.01
Revenue Estimate
60.949M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.35%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.83
Upside
+ 131.09%
From current price of $5.12 to mean target of $11.83, Based on 17 analyst forecasts
Low
$7.07
Median
$12.24
High
$17.85

Price Target Revisions

1 Month
-2.52%
3 Months
3.57%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for NUVB. The average price target is 11.83 USD. This implies a price increase of 131.09% is expected in the next year compared to the current price of 5.12.
The average price target has been revised upward by 3.57% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NUVB Current Analyst RatingNUVB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

NUVB Historical Analyst RatingsNUVB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
82.35%
NUVB was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NUVB.
In the previous month the buy percentage consensus was at a similar level.
NUVB was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-16WedbushReiterate Outperform -> Outperform
2026-04-02WedbushReiterate Outperform -> Outperform
2026-03-27WedbushReiterate Outperform -> Outperform
2026-03-03UBSMaintains Neutral -> Neutral
2026-03-03RBC CapitalMaintains Outperform -> Outperform
2026-02-10WedbushReiterate Outperform -> Outperform
2026-01-21RBC CapitalMaintains Outperform -> Outperform
2026-01-12HC Wainwright & Co.Maintains Buy -> Buy
2026-01-07UBSInitiate Neutral
2025-12-11HC Wainwright & Co.Maintains Buy -> Buy
2025-12-01HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-24Truist SecuritiesInitiate Buy
2025-11-20CitizensMaintains Market Outperform -> Market Outperform
2025-11-19B. Riley SecuritiesInitiate Buy
2025-11-04CitizensMaintains Market Outperform -> Market Outperform
2025-11-04RBC CapitalMaintains Outperform -> Outperform
2025-10-13WedbushReiterate Outperform -> Outperform
2025-09-30JefferiesInitiate Buy
2025-09-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-08WedbushReiterate Outperform -> Outperform
2025-08-08RBC CapitalMaintains Outperform -> Outperform
2025-06-25JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-06-17RBC CapitalMaintains Outperform -> Outperform
2025-06-11WedbushMaintains Outperform -> Outperform
2025-06-02JMP SecuritiesReiterate Market Outperform -> Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.01
Revenue Estimate
60.949M
Revenue Q2Q
1,876.30%
EPS Q2Q
96.81%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
20.59%
Revenue (3 Months)
90.04%
EPS (1 Month)
91.11%
EPS (3 Months)
97.40%

Next Earnings Summary

NUVB is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 60.95M USD.
The next earnings revenue estimate has been revised upward by 90.04% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NUVB revenue by date.NUVB revenue by date.
7.873M62.902M
698.96%		191.11M
203.82%		302.29M
58.18%		430.87M
42.54%		558.17M
29.54%		767.83M
37.56%		1.037B
35.06%		1.309B
26.23%		1.541B
17.72%
EBITDA
YoY % growth
NUVB ebitda by date.NUVB ebitda by date.
-99.6M
11.17%		-166.874M
-67.54%		-211.325M
-26.64%		-186.629M
11.69%		-49.286M
73.59%		-39.29M
20.28%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
NUVB ebit by date.NUVB ebit by date.
-99.822M
11.14%		-167.557M
-67.86%		-213.064M
-27.16%		-167.407M
21.43%		-108.935M
34.93%		-57.177M
47.51%		57.886M
201.24%		222.64M
284.62%		443.15M
99.04%		669.09M
50.98%		852.99M
27.49%
Operating Margin
NUVB operating margin by date.NUVB operating margin by date.
N/A-2,128.25%-338.72%-87.60%-36.04%-13.27%10.37%29.00%42.73%51.11%55.35%
EPS
YoY % growth
NUVB eps by date.NUVB eps by date.
-0.34
29.17%		-0.52
-52.94%		-0.60
-15.38%		-0.49
18.49%		-0.27
45.15%		-0.05
82.22%		-0.17
-263.64%		0.08
147.06%		0.54
562.50%		0.86
58.49%		1.02
19.05%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.01
96.81%		-0.18
-6.56%		-0.15
3.91%		-0.16
-42.80%		-0.06
-1,120.00%		-0.05
74.66%		-0.05
69.48%		0.03
116.23%		0.03
140.98%		0.02
153.33%		0.02
152.17%		0.02
-12.00%
Revenue
Q2Q % growth		60.949M
1,876.30%		32.328M
568.90%		43.223M
229.44%		54.583M
30.38%		98.357M
61.38%		77.009M
138.21%		87.179M
101.70%		99.371M
82.05%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-17.366M
70.57%		-48.439M
23.82%		-46.282M
17.99%		-43.452M
-27.66%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NUVB Yearly Revenue VS EstimatesNUVB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
NUVB Yearly EPS VS EstimatesNUVB Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.30%
EPS Next 5 Year
16.39%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
92.95%
Revenue Next 5 Year
66.51%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
22.04%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NUVATION BIO INC / NUVB Forecast FAQ

What is the average price target for NUVATION BIO INC (NUVB) stock?

17 analysts have analysed NUVB and the average price target is 11.83 USD. This implies a price increase of 131.09% is expected in the next year compared to the current price of 5.12.

Can you provide the upcoming earnings date for NUVATION BIO INC?

NUVATION BIO INC (NUVB) will report earnings on 2026-05-05.

Can you provide the consensus estimates for NUVATION BIO INC next earnings?

The consensus EPS estimate for the next earnings of NUVATION BIO INC (NUVB) is -0.01 USD and the consensus revenue estimate is 60.95M USD.

Can you provide the expected long term growth rate for NUVATION BIO INC stock?

The expected long term growth rate for NUVATION BIO INC (NUVB) is 92.95%.